Prophase Labs

Prophase Labs Receivables

The Accounts Receivable of Prophase Labs (PRPH) as of Oct 27, 2026 is 20.66 M USD. In the previous year, Accounts Receivable was 36.31 M USD — a change of -43.10% (lower).

Receivables

20.66 MUSD

YoY

-43.10%

Last updated:

Accounts Receivable of Prophase Labs is 2024 20.66 M USD. Accounts Receivable of Prophase Labs was 2023 36.31 M USD. It decreases by -43.10% lower compared to the previous year.

The Prophase Labs Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2017
1.95 M USD
Jan 1, 2018
2.97 M USD
Jan 1, 2019
2.01 M USD
Jan 1, 2020
3.16 M USD
Jan 1, 2021
37.71 M USD
Jan 1, 2022
37.05 M USD
Jan 1, 2023
36.31 M USD
Jan 1, 2024
20.66 M USD
The Prophase Labs Receivables history
YEARReceivablesYoY
20.66 MUSD-43.10%
36.31 MUSD-1.99%
37.05 MUSD-1.75%
37.71 MUSD+1,093.35%
3.16 MUSD+57.21%
2.01 MUSD-32.32%
2.97 MUSD+52.31%
1.95 MUSD-66.20%
5.77 MUSD+44.25%
4.00 MUSD-31.51%
5.84 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Prophase Labs Stock analysis

What does Prophase Labs do? ProPhase Labs, Inc. generates revenue through the sale of over-the-counter consumer healthcare products and dietary supplements. The company develops and markets TK Supplements, featuring LEGENDZ XL for male sexual enhancement, TRIPLE EDGE XL for daily energy and stamina, and SUPER PROSTAFLOW plus for prostate and urinary health. ORXx Complete, a dietary supplement, and ORXx cough/cold drops are also sold to national wholesalers, distributors, and retail chains including pharmacies and mass merchandise stores. The firm targets health-conscious consumers seeking natural solutions through its OTC drug and supplement lines. Its products are distributed via national wholesalers and retailers such as independent and chain drugstores, food stores, and mass merchandise outlets. ProPhase Labs focuses on direct sales to these established retail segments without third-party branding or partnerships. Revenue streams are derived from the consistent demand for male enhancement, energy, and health supplements within the OTC market. The company's product portfolio caters specifically to customers interested in natural health products, with no additional services or digital platforms beyond physical product sales. Prophase Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Prophase Labs stock

Accounts Receivable of Prophase Labs is 20.66 M USD in 2024.

Accounts Receivable of Prophase Labs changed from 36.31 M USD to 20.66 M USD, representing a -43.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Prophase Labs since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Prophase Labs historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Prophase Labs

All Key Metrics — Prophase Labs